Skip to content
healthcare.dev

Alfuzosin Hydrochloride

NDC 57237-114, Alfuzosin Hydrochloride, tablet, film coated, extended release, from Rising Pharma Holdings, Inc..

Product NDC
57237-114
Status
Listed
Labeler
Rising Pharma Holdings, Inc.
Dosage form
TABLET, FILM COATED, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA079060
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/57237-114 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ALFUZOSIN HYDROCHLORIDE10 mg/1

Pharmacologic classes

Adrenergic alpha-Antagonists [MoA]; alpha-Adrenergic Blocker [EPC]

Package NDCNDC-11Package
57237-114-0157237011401100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (57237-114-01)
57237-114-0557237011405500 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (57237-114-05)
57237-114-905723701149090 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (57237-114-90)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/43675e9d-a361-4109-9ae1-54d80580fbbd
  • NADAC price for package 57237011490

    GET /v1/drugs/nadac/57237011490

Use it

Look up 57237-114 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/57237-114 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 57237-114. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.